FTDI
First Trust Direct Indexing’s United Therapeutics UTHR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,669
| Closed | -$956K | – | 881 |
|
|
2024
Q3 | $956K | Buy |
2,669
+309
| +13% | +$111K | 0.05% | 358 |
|
|
2024
Q2 | $752K | Buy |
2,360
+253
| +12% | +$80.6K | 0.05% | 385 |
|
|
2024
Q1 | $484K | Buy |
2,107
+580
| +38% | +$133K | 0.04% | 478 |
|
|
2023
Q4 | $336K | Buy |
1,527
+187
| +14% | +$41.1K | 0.03% | 551 |
|
|
2023
Q3 | $303K | Sell |
1,340
-779
| -37% | -$176K | 0.03% | 512 |
|
|
2023
Q2 | $468K | Buy |
2,119
+515
| +32% | +$114K | 0.05% | 431 |
|
|
2023
Q1 | $359K | Buy |
1,604
+239
| +18% | +$53.5K | 0.04% | 489 |
|
|
2022
Q4 | $380K | Sell |
1,365
-184
| -12% | -$51.2K | 0.05% | 449 |
|
|
2022
Q3 | $324K | Buy |
1,549
+37
| +2% | +$7.74K | 0.05% | 444 |
|
|
2022
Q2 | $356K | Buy |
1,512
+134
| +10% | +$31.6K | 0.05% | 421 |
|
|
2022
Q1 | $247K | Buy |
1,378
+114
| +9% | +$20.4K | 0.03% | 561 |
|
|
2021
Q4 | $273K | Sell |
1,264
-13
| -1% | -$2.81K | 0.04% | 519 |
|
|
2021
Q3 | $236K | Buy |
1,277
+76
| +6% | +$14K | 0.03% | 547 |
|
|
2021
Q2 | $215K | Buy |
+1,201
| New | +$215K | 0.03% | 539 |
|
|
2021
Q1 | – | Sell |
-887
| Closed | -$135K | – | 968 |
|
|
2020
Q4 | $135K | Buy |
+887
| New | +$135K | 0.04% | 429 |
|